These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30266766)

  • 1. Pharmacodynamic Effects, Pharmacokinetics, and Metabolism of the Synthetic Cannabinoid AM-2201 in Male Rats.
    Carlier J; Wohlfarth A; Salmeron BD; Scheidweiler KB; Huestis MA; Baumann MH
    J Pharmacol Exp Ther; 2018 Dec; 367(3):543-550. PubMed ID: 30266766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of [1-(5-fluoropentyl)-1H-indol-3-yl](naphthalene-1-yl)methanone (AM-2201) and 13 metabolites in human and rat plasma by liquid chromatography-tandem mass spectrometry.
    Carlier J; Scheidweiler KB; Wohlfarth A; Salmeron BD; Baumann MH; Huestis MA
    J Chromatogr A; 2016 Jun; 1451():97-106. PubMed ID: 27208987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of new classes of recreational drugs in sewage: synthetic cannabinoids and amphetamine-like substances.
    Reid MJ; Derry L; Thomas KV
    Drug Test Anal; 2014; 6(1-2):72-9. PubMed ID: 23460377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of Nine Synthetic Cannabinoid Receptor Agonists Encountered in Clinical Casework: Major in vivo Phase I Metabolites of AM-694, AM-2201, JWH-007, JWH-019, JWH-203, JWH-307, MAM-2201, UR-144 and XLR-11 in Human Urine Using LC-MS/MS.
    Hutter M; Broecker S; Kneisel S; Franz F; Brandt SD; Auwarter V
    Curr Pharm Biotechnol; 2018; 19(2):144-162. PubMed ID: 29745330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of the designer drug and synthetic cannabinoid receptor agonist AM-2201 regarding its chemistry and metabolism.
    Hutter M; Moosmann B; Kneisel S; Auwärter V
    J Mass Spectrom; 2013 Jul; 48(7):885-94. PubMed ID: 23832945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apparent Affinity Estimates and Reversal of the Effects of Synthetic Cannabinoids AM-2201, CP-47,497, JWH-122, and JWH-250 by Rimonabant in Rhesus Monkeys.
    Hruba L; McMahon LR
    J Pharmacol Exp Ther; 2017 Aug; 362(2):278-286. PubMed ID: 28533288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic properties of the synthetic cannabinoid JWH-018 in oral fluid after inhalation.
    Toennes SW; Geraths A; Pogoda W; Paulke A; Wunder C; Theunissen EL; Ramaekers JG
    Drug Test Anal; 2018 Apr; 10(4):644-650. PubMed ID: 28967189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excretion of metabolites of the synthetic cannabinoid JWH-018 in urine after controlled inhalation.
    Toennes SW; Geraths A; Pogoda W; Paulke A; Wunder C; Theunissen EL; Ramaekers JG
    J Pharm Biomed Anal; 2018 Feb; 150():162-168. PubMed ID: 29245085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of the synthetic cannabinoid, 5F-MDMB-PICA, in male rats.
    Krotulski AJ; Garibay N; Walther D; Walton SE; Mohr ALA; Logan BK; Baumann MH
    Neuropharmacology; 2021 Nov; 199():108800. PubMed ID: 34547333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of XLR-11 and its metabolites in hair by liquid chromatography-tandem mass spectrometry.
    Park M; Yeon S; Lee J; In S
    J Pharm Biomed Anal; 2015 Oct; 114():184-9. PubMed ID: 26070160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of AM-2201 metabolites in urine and comparison with JWH-018 abuse.
    Jang M; Yang W; Shin I; Choi H; Chang H; Kim E
    Int J Legal Med; 2014 Mar; 128(2):285-94. PubMed ID: 23884698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of Synthetic Cannabinoids JWH-210, RCS-4 and Δ 9-Tetrahydrocannabinol After Intravenous Administration to Pigs.
    Schaefer N; Kettner M; Laschke MW; Schlote J; Ewald AH; Menger MD; Maurer HH; Schmidt PH
    Curr Neuropharmacol; 2017; 15(5):713-723. PubMed ID: 27834143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic properties of the synthetic cannabinoid JWH-018 and of its metabolites in serum after inhalation.
    Toennes SW; Geraths A; Pogoda W; Paulke A; Wunder C; Theunissen EL; Ramaekers JG
    J Pharm Biomed Anal; 2017 Jun; 140():215-222. PubMed ID: 28365515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic patterns of JWH-210, RCS-4, and THC in pig urine elucidated using LC-HR-MS/MS: Do they reflect patterns in humans?
    Schaefer N; Helfer AG; Kettner M; Laschke MW; Schlote J; Ewald AH; Meyer MR; Menger MD; Maurer HH; Schmidt PH
    Drug Test Anal; 2017 Apr; 9(4):613-625. PubMed ID: 27328899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous determination of five naphthoylindole-based synthetic cannabinoids and metabolites and their deposition in human and rat hair.
    Kim J; Park Y; Park M; Kim E; Yang W; Baeck S; Lee S; Han S
    J Pharm Biomed Anal; 2015 Jan; 102():162-75. PubMed ID: 25282599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. JWH-018 ω-OH, a shared hydroxy metabolite of the two synthetic cannabinoids JWH-018 and AM-2201, undergoes oxidation by alcohol dehydrogenase and aldehyde dehydrogenase enzymes in vitro forming the carboxylic acid metabolite.
    Holm NB; Noble C; Linnet K
    Toxicol Lett; 2016 Sep; 259():35-43. PubMed ID: 27421777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative measurement of JWH-018 and JWH-073 metabolites excreted in human urine.
    Moran CL; Le VH; Chimalakonda KC; Smedley AL; Lackey FD; Owen SN; Kennedy PD; Endres GW; Ciske FL; Kramer JB; Kornilov AM; Bratton LD; Dobrowolski PJ; Wessinger WD; Fantegrossi WE; Prather PL; James LP; Radominska-Pandya A; Moran JH
    Anal Chem; 2011 Jun; 83(11):4228-36. PubMed ID: 21506519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids.
    Sobolevsky T; Prasolov I; Rodchenkov G
    Drug Test Anal; 2012 Oct; 4(10):745-53. PubMed ID: 23042760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for the synthetic cannabinoid JWH-018 and its major metabolites in human doping controls.
    Möller I; Wintermeyer A; Bender K; Jübner M; Thomas A; Krug O; Schänzer W; Thevis M
    Drug Test Anal; 2011 Sep; 3(9):609-20. PubMed ID: 20872894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biotransformation of synthetic cannabinoids JWH-018, JWH-073 and AM2201 by Cunninghamella elegans.
    Watanabe S; Kuzhiumparambil U; Winiarski Z; Fu S
    Forensic Sci Int; 2016 Apr; 261():33-42. PubMed ID: 26907475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.